// App-Quantinova.ai

Filters

Biomarkers











Conference Name











Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























1151 Abstracts

Factors Associated with Damage Accrual and Survival in Chinese Patients with Systemic Lupus Erythematosus (SLE): A Prospective Cohort Analysis of 747 Patients

Chi Chiu Mok - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Hydroxychloroquine Dosing and Disease Activity in a Large Multi-Racial Lupus Cohort

Jennifer M. Grossman - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Hydroxychloroquine Use Is Associated Independently with Improved Quality of Life in Systemic Lupus Erythematosus

Meenakshi Jolly - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Hydroxylchloroquine Use Is Associated with Decreased Soluble TNF Receptor Levels in SLE Patient Samples

Rufei Lu - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Impact of Physician- Adherence to Treat-to-Target Strategy on Outcomes in Early Rheumatoid Arthritis

Laura Kuusalo - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Impact of Provider Specialty on the Diagnosis and Management of Systemic Lupus Erythematosus in the American Indian/Alaska Native Population

John McDougall Jr - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Impaired Speckle Tracking As a Marker of Subclinical Left Ventricular Dysfunction in Patients Affected By Primary Sjogrens Syndrome

Fabiola Atzeni - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular dysfunction

Hydroxychloroquine

Infliximab Versus Conventional Combination Treatment and Work Loss in Early RA over 7 Years: A Randomized Trial

Jonas K Eriksson - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Treat to Target in Routine Clinical Practice

Mohammad Solaiman - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Use of Hydroxychloroquine Associated with Improved Lipid Profile in Rheumatoid Arthritis Patients

Jose Felix Restrepo - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Patient-Physician Discordance of Disease Activity Assessments Predicts Inadequate Treatment Response in Early Rheumatoid Arthritis

John M. Davis III - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Poor Adherence to Medications for Systemic Lupus Erythematosus Predicts Higher Health Care Utilization in U.S. Medicaid Beneficiaries

Jinoos Yazdany - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Predictors of Radiologic Disease Progression during the Rheumatoid Arthritis Comparison of Active Therapies Trial

Alan Erickson - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Probability of 3 and 6 Month Complete Response in Lupus Nephritis

Homa Timlin - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus nephritis

Hydroxychloroquine

Safety of Gardasil Vaccine in Systemic Lupus Erythematosu, Trial Update

J. Patricia Dhar - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Deep vein thrombosis

Hydroxychloroquine

Screening Behavior and Prevalence of Hepatitis C Virus in Mexico

Cassandra Skinner-Taylor - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Hepatitis C

Hydroxychloroquine

Serum Survivin in Early Rheumatoid Arthritis

Adrian Levitsky - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

The Association Between Hydroxychloroquine Treatment and Cardiovascular Morbidity Among Rheumatoid Arthritis Patients

Michael Shapiro - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

Hydroxychloroquine

The Cellular Effects of ANTI-Factor Xa Antibodies Isolated from Patients with Antiphospholipid Syndrome ARE Inhibited By Factorxa Inhibitors, Hydroxychloroquine and Fluvastatin

Bahar Artim-Esen - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Antiphospholipid syndrome

Hydroxychloroquine

PROTEIN BIOMARKERS IMPROVES THE PREDICTION OF CLINICAL RESPONSE TO METHOTREXATE STEP-UP STRATEGY IN EARLY RA PATIENTS

X.M. Teitsma - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Copyright © 2026. QuantiNova All rights reserved